Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alendronate Prevents Microarchitectural Deterioration of Trabecular Bone in Early Postmenopausal

NCT00504166 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT00504166
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00504166 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alendronate Prevents Microarchitectural Deterioration of Trabecular Bone in Early Postmenopausal
Lead sponsor
University of California, San Francisco
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2006
Completion date
April 30, 2009
Enrollment
53 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteopenia, osteoporosis